Misoprostol Regimen for MTP at 7 Weeks
For medication termination of pregnancy at 7 weeks gestation, use mifepristone 200 mg orally followed 24-48 hours later by misoprostol 800 mcg buccally or vaginally, administered at home. This combination regimen is significantly more effective than misoprostol alone and represents the evidence-based standard of care 1, 2.
Recommended Regimen
The optimal protocol consists of:
- Mifepristone 200 mg taken orally in the clinic
- Followed 24-48 hours later by misoprostol 800 mcg administered buccally or vaginally
- Location: Misoprostol can be safely taken at home
- Route: Either buccal (held in cheeks for 30 minutes then swallowed) or vaginal administration are equally effective
This regimen achieves 97-98% efficacy at 7 weeks gestation, which falls within the 36-42 day gestational age range where success rates are highest 2.
Why This Regimen Works Best
The combination of mifepristone plus misoprostol is substantially superior to misoprostol alone. While the provided guidelines [3-3] focus on second-trimester abortion (14-27 weeks), the principles of combination therapy apply even more strongly in early pregnancy. Research demonstrates that at 7 weeks:
- Mifepristone 200 mg is as effective as 600 mg when combined with misoprostol 3
- The 24-48 hour interval between medications is the traditional and well-validated timing 3, 1
- Home administration of misoprostol is safe and effective through 63 days (9 weeks) gestation 2
Critical Pitfalls to Avoid
Do not use concurrent administration (giving both medications at the same time). Recent evidence shows concurrent dosing has significantly lower success rates (68.8% vs 84.3%) and higher rates of continuing pregnancy (13.4% vs 2.8%) compared to the standard 48-hour interval 4. Patients choosing concurrent administration require counseling about substantially reduced efficacy.
Do not use misoprostol-only regimens unless mifepristone is unavailable. Misoprostol alone has much lower efficacy, with one study showing only 86% complete abortion at <7 weeks using repeated 400 mcg sublingual doses 5. The combination regimen is clearly superior.
Do not use lower misoprostol doses. The 800 mcg dose is evidence-based for early pregnancy. Lower doses (200-400 mcg) are used in second-trimester protocols but are inadequate for first-trimester medication abortion 3.
What to Expect
- Bleeding duration: Average 9-16 days, with median around 20 days 5, 1
- Cramping and bleeding are expected effects and should be managed with NSAIDs
- Side effects from misoprostol include low-grade fever, nausea, vomiting, diarrhea, and chills—all manageable with supportive care 1
- Time to expulsion: Most tissue passage occurs within hours to days after misoprostol
Follow-Up Requirements
Confirm complete abortion using:
- Clinical history combined with serial quantitative β-hCG levels, OR
- Urine pregnancy testing, OR
- Ultrasonography 1
Rare complications include ongoing pregnancy, infection, hemorrhage, undiagnosed ectopic pregnancy, and need for unplanned uterine aspiration—all occurring in <1-3% of cases 1, 2.
Alternative Only If Mifepristone Unavailable
If mifepristone is truly unavailable, misoprostol-only regimens using 400 mcg sublingual every 3 hours for up to 3-5 doses can be considered, but expect lower efficacy (86% vs 97-98%) and counsel patients accordingly 5. However, this is a second-line approach—the mifepristone-misoprostol combination should always be the first choice when available.